Posts in: October, 2019

New All-Agency Executive Orders May Undermine 340B Guidance

On October 9, 2019, the White House issued two executive orders with potential implications on HRSA’s ability to enforce its sub-regulatory guidance, including its patient

29 Oct

OPA Reevaluates 340B Program Policies

340B Health reports that Capt. Krista Pedley, the Director of OPA, stated last week at the Medicaid Drug Rebate Conference that OPA is reevaluating its

3 Oct

CMS To Survey Hospitals About Acquisition Costs for 340B Drugs

In a Federal Register notice issued yesterday, CMS announced that it intends to survey hospitals on their acquisition costs for covered outpatient drugs purchased under the 340B

1 Oct
Top